Eli Lilly has released a brand new program that enables self-spend sufferers to purchase the weight-loss drug Zepbound for as very little as $399 per month—lower than half the list price of other incretin medicines useful for clients with obesity.No, Tirzepatide is just not insulin. It's really a GLP-1 and GIP receptor agonist that assists contro